Portage Biotech Inc. | Balance Sheet
Fiscal year is April-March. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,323.50
2,032.10
1,718.30
4,688.90
59,071.90
9,762.20
Total Accounts Receivable
106.80
227.20
-
-
16.40
36.10
Other Current Assets
-
-
17.60
203.90
47.70
20.60
Total Current Assets
3,430.40
2,259.30
1,735.90
4,892.90
59,136.10
9,818.90
Net Property, Plant & Equipment
5.60
4.10
-
-
-
-
Total Investments and Advances
-
-
-
700.00
700.00
1,780.50
Long-Term Note Receivable
-
-
-
-
67.50
1,297
Intangible Assets
-
3,000.00
3,000.00
7,036.00
-
-
Total Assets
3,436.00
5,263.40
4,735.90
12,628.80
59,903.60
12,896.40
Accounts Payable
447.50
134.70
-
-
-
Other Current Liabilities
-
57.20
620.60
299.70
109.10
Total Current Liabilities
447.50
192.00
620.60
299.70
109.10
Long-Term Debt
-
-
-
-
180.80
Other Liabilities
-
-
-
-
19.60
Total Liabilities
447.50
192.00
620.60
299.70
309.40
Common Equity (Total)
2,988.50
2,393.10
2,659.80
10,269.40
59,594.10
Total Shareholders' Equity
2,988.50
2,393.10
2,659.80
10,269.40
59,594.10
Total Equity
2,988.50
5,071.40
4,115.30
12,329.10
59,594.10
Liabilities & Shareholders' Equity
3,436.00
5,263.40
4,735.90
12,628.80
59,903.60
Accumulated Minority Interest
-
2,678.30
1,455.50
2,059.70
-
About Portage Biotech
View Profile
